James Compton-Dando is an accomplished healthcare professional currently serving as the Global Head for Essentials in Cardiovascular, Thrombosis, Neurology, and Oncology at Sanofi. With a solid foundation in pharmacology from The University of Dundee, James possesses extensive experience in medical sales and brand management, having held positions at Merck Sharpe & Dohme, sanofi-aventis, and Sanofi. Notably, James led the UK launch of the novel PCSK9 inhibitor, Praluent, and has developed pre-launch marketing strategies for various cardiovascular products. They have also obtained prestigious marketing qualifications, including an Advanced Diploma in Communications Studies and a CIM Professional Diploma in Marketing.
This person is not in any teams
This person is not in any offices